6041, Charleroi, Hainaut, Belgium
Eric Leire MD, Bertrand Alexandre
2020
10
Private company
Seed
Longevitytech.fund
Genomic instability
GENFLOW is dedicated to the development and commercialization of novel therapeutics targeting aging in dogs and humans. Aging is not a natural fatality. There is no rationale for a limited lifespan. Aging can now be considered as a risk factor that we can treat. By treating aging, we believe that GENFLOW can contribute to decrease healthcare costs and lessen the emotional and societal burden that comes with an aging population.